Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | USP2 | O75604 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.31 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8222324 | 0.93 | USP2 (0.40) | ALDH1A1MAPTUSP2CYP3A4SMN1; SMN2 | |
| SCHEMBL8887818 | 0.91 | USP2 (0.42) | ALDH1A1MAPTUSP2CYP3A4SMN1; SMN2 | |
| SCHEMBL8211764 | 0.91 | USP2 (0.42) | ALDH1A1MAPTUSP2CYP3A4SMN1; SMN2 | |
| SCHEMBL7561555 | 0.85 | — | — | |
| SCHEMBL8731905 | 0.81 | ALDH1A1 (0.36) | ALDH1A1MAPTUSP2CYP3A4SMN1; SMN2 | |
| SCHEMBL237011 | 0.79 | — | — | |
| SCHEMBL23064132 | 0.77 | — | — | |
| SCHEMBL483567 | 0.77 | — | — | |
| SCHEMBL23064168 | 0.76 | — | — | |
| SCHEMBL23064167 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 496 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1675880-B1 | METHOD FOR PARTIAL OR TOTAL OXIDATION OF ONE OR SEVERAL THIOCARBONYLTHIO ENDS OF A POLYMER OBTAINED BY RADICAL POLYMERISATION CONTROLLED BY REVERSIBLE ADDITION-CLEAVAGE | RHODIA CHIMIE SA (FR) | 2019-03-13 | — | — | EP | claimed |
| EP-1527105-B1 | SYNTHESIS OF STATISTICAL MICROGELS BY MEANS OF CONTROLLED RADICAL POLYMERISATION | RHODIA CHIMIE SA (FR) | 2009-02-25 | — | — | EP | claimed |
| EP-0942329-B1 | NOVEL PROCESS FOR PREPARING RESISTS | CLARIANT FINANCE BVI LTD (VG) | 2002-11-13 | — | — | EP | claimed |
| US-20010024765-A1 | Novel process for preparing resists | MERCK PATENT GMBH (DE) | 2001-09-27 | — | — | US | claimed |
| US-6284427-B1 | Process for preparing resists | CLARIANT FINANCE (BVI) LIMITED (VG) | 2001-09-04 | — | — | US | claimed |
| US-6187897-B1 | USEFUL IN COATING AND PRINTING; CURABLE BY ANY ONE OF CONVENTIONAL TRIGGERS SUCH AS HEATING, ULTRAVIOLET LIGHT, INFRARED LIGHT, ELECTRON BEAMS AND GAMMA RAYS | TOYO INK MANUFACTURING CO., LTD. (JP) | 2001-02-13 | — | — | US | claimed |
| EP-0942329-A1 | NOVEL PROCESS FOR PREPARING RESISTS | Clariant International Ltd. (CH) | 1999-09-15 | — | — | EP | claimed |
| EP-0796874-A2 | Process for the preparation of polymers containing peroxycarboxylic groups | BASF AKTIENGESELLSCHAFT (DE) | 1997-09-24 | — | — | EP | claimed |
| CN-114450350-B | Resin composition, resin composition film, cured film, hollow structure using same, and semiconductor device | 东丽株式会社 | 2024-06-28 | — | — | CN | disclosed |
| US-20240176239-A1 | NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION FILM, CURED PRODUCT, PREPARATION METHOD OF CURED PRODUCT, HOLLOW STRUCTURE, AND ELECTRONIC COMPONENT | TORAY INDUSTRIES, INC. (JP) | 2024-05-30 | — | — | US | disclosed |
| WO-2024106220-A1 | RESIN FOR ACTIVE ENERGY RAY CURABLE INK, COMPOSITION FOR ACTIVE ENERGY RAY CURABLE INK, INK COMPOSITION, AND PRINTED MATERIAL | ＤＩＣグラフィックス株式会社 | 2024-05-23 | — | — | WO | disclosed |
| CN-117999501-A | Polarizing film, image display device, and method for manufacturing polarizing film | 日东电工株式会社 | 2024-05-07 | — | — | CN | disclosed |
| WO-2024070348-A1 | RESIN COMPOSITION, CURED PRODUCT, SCINTILLATOR PANEL, AND INDUCTOR | 東レ株式会社 | 2024-04-04 | — | — | WO | disclosed |
| US-11926581-B2 | Sulfonium salt, photoacid generator, curable composition, and resist composition | SAN-APRO LIMITED (JP) | 2024-03-12 | — | — | US | disclosed |
| US-4248960-A | Radiation responsive relief imageable plastic laminate | W. R. GRACE & CO. (US) | 1981-02-03 | — | — | US | disclosed |
| US-4234676-A | TACK-FREE COATINGS OBTAINED FROM PHOTOPOLYMERIZING AN ADDITION POLYMER AND AN ESTER OF METHACRYLIC OR ACRYLIC ACID | W. R. GRACE & CO. (US) | 1980-11-18 | — | — | US | disclosed |
| US-4190602-A | PHOTOCHEMICAL SENSITIZERS BY REACTION OF SULFUROUS ACID ESTER OR THIONYL CHLORIDE AND A PRIMARY ALCOHOL | CIBA-GEIGY CORPORATION (US) | 1980-02-26 | — | — | US | disclosed |
| US-4179531-A | PHOTOPOLYMERIZATION, PRINTING PLATES | W. R. GRACE & CO. (US) | 1979-12-18 | — | — | US | disclosed |
| US-4172065-A | Solvent system for polyacrylonitrile and other polymers and use of same for casting film, for spinning fibers and for coating | Trian Company (US) | 1979-10-23 | — | — | US | disclosed |
| US-4162919-A | Laminates for the manufacture of flexographic printing plates using block copolymers | BASF AKTIENGESELLSCHAFT (DE) | 1979-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11926581-B2 | Sulfonium salt, photoacid generator, curable composition, and resist composition | H1-0, SPIN1, IK | ALDH1A1 2453/4885MAPT 3742/4885USP2 1875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.